Latest IPO Information

Ravelcare Ltd. IPO

IPO Date: Dec 1 to Dec 3 2025

Listing Date: Dec 8 2025

Objective

1. Marketing and advertisement expenses toward enhancing the awareness and visibility of our brand
2. Setting up a new manufacturing facility at Mauje-Peth in Amravati (“Proposed facility”)
3. General corporate purposes

IPO Details

Face Value ₹ 10.00 Per Share
Issue Size ₹ 16.35 - 17.28 Cr
Price Band ₹ 123.00 - ₹ 130.00 Per Share
Market LOT 2000 shares
Issue Type Book building

About Company

Our Company specializes in personalized haircare, skincare and bodycare products within the beauty and personal care industry. Our core mission is to redefine beauty standards by offering bespoke products meticulously crafted to meet the needs and preferences of customers. We focus on harnessing top-tier ingredients, cutting-edge product research, and direct customer feedback to curate exceptional formulations that deliver transformative results. Our dedication to personalized beauty regimens empowers individuals to embrace their distinctiveness and enhances their self-assurance. We aim to fos .... ter a movement towards personalized self-care by revolutionizing how people perceive and engage with beauty, thereby enhancing the overall customer experience. We believe that our marketing strategy is powered by our customer centric approach across various aspects of our business model, including our digital distribution channel and our data driven marketing and consumer engagement model. Read More
Address

12th Floor, Flat 1211, 9 Business Bay Khakhar Property, Off New Link Road Mindspace Behind Evershine Mall, Chincholi Bunder, Malad (W)

City

Mumbai

State

Maharashtra

Pincode

400064

Phone

8433980120

Email

esha@ravelcare.com

Website

www.ravelcare.com

About IPO

Listed At BSE/NSE
Lead Manager Marwadi Chandarana Intermediaries Brokers Pvt Ltd.
Promoters
Maheshkumar Ramchandra Varma
Anita Mahesh Varma
Ayush Mahesh Varma

Promoter's Holding

Registrar

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

040 - 67162222/18003094001
einward.ris@kfintech.com
www.kfintech.com

Latest News

Sep
23
2026
EQUITY Posted on Sep 23rd 2026

Ravelcare submits voting results

Ravelcare has informed that 8th Annual General Meeting of the company was held on Wednesday, September 23, 2026 through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) in compliance with the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. A disclosure of voting results of the meeting in terms of Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the businesses considered and approved by the shareholders is enclosed, together with the Scrutinizer's Report on e-voting. A copy of the same is also being placed on the Company's website www.ravelcare.com.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
30
2026
FINANCE Posted on Oct 30th 2026

Currency futures for November expiry trade almost flat with 6.02% increase in OI

The partially convertible rupee is currently trading at 95.26, tad stronger compared to its Thursday’s close at 95.2650. The rupee opened at 95.21 and touched day's high of 95.2850 and low of 95.19.
The November currency futures were trading at 95.51 with a spread of 0.0100 and a volume of 1,26,076. The contract opened at 95.4500 stronger from its previous closing of 95.5075. The open interest (OI) stood at 7,86,692 up by 6.02% compared to its previous close of 7,42,005.
Read More
Oct
30
2026
EQUITY Posted on Oct 30th 2026

Rubicon Research informs about updates

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Rubicon Research has informed that the United States Food and Drug Administration (US FDA) conducted an unannounced inspection (triggered by a product filing) of the company’s manufacturing facility located at Plot No. K30/4 & 30/5, Additional M.I.D.C., Anand Nagar, Ambernath, Maharashtra, India from Wednesday, 21 October 2026 to Thursday, 29 October 2026. This was a comprehensive GMP inspection in addition to the product application under review. Upon conclusion, a Form 483 containing 3 observations with respect to system improvement and 2 observations with respect to product application under review were issued, all 5 of which are procedural in nature and do not relate to data integrity. The company is confident of working closely with the regulator to successfully conclude the evaluation in a timely manner. All its manufacturing as well as R&D facilities have now been inspected by the US FDA in the recent past and it has enclosed the status of all its operational facilities.

The above information is a part of company’s filings submitted to BSE.
Read More
Oct
30
2026
EQUITY Posted on Oct 30th 2026

Fabtech Technologies informs about investor presentation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fabtech Technologies has informed that it enclosed the Investor Presentation in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
30
2026
EQUITY Posted on Oct 30th 2026

NMS Global informs about clarification on price movement

With reference to the clarification dated October 27, 2026, regarding the significant movement in the price of the securities of the Company, NMS Global has submitted: The Company is not aware of any undisclosed material event, information, or development that would require disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which could have a bearing on the movement in the price of its securities. The Company has been making disclosures to the Stock Exchanges from time to time in accordance with the applicable provisions of the SEBI (LODR) Regulations, 2015. The Company remains committed to ensuring timely disclosure of all material information and maintaining transparency with its shareholders and the investing public. The movement in the price of the Company's securities appears to be market-driven, and the Company is not in a position to comment on the specific reasons for such movement. The company has confirmed that, should any material event or information requiring disclosure arise, the Company shall make the requisite disclosure to the Stock Exchanges in accordance with applicable regulatory requirements.

The above information is a part of company’s filings submitted to BSE.

Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Ravelcare Ltd. IPO?

The issue size of Ravelcare Ltd. IPO is ₹16.35 - 17.28 crore.

The Ravelcare Ltd. IPO opens for subscription on 2025-12-01 and closes on 2025-12-03.

The price range of Ravelcare Ltd. IPO is ₹123.00 to ₹130.00.

The lot size of Ravelcare Ltd. IPO is 2000 shares.

The registrar of Ravelcare Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).

Ravelcare Ltd. IPO will be listed on BSE/NSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-12-03 to increase your chances.

The listing date of Ravelcare Ltd. IPO is 2025-12-08.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore